Skip to main content

1 August 2006

SMITHS Medical, part of the global engineering business Smiths Group, announced today it has launched a new range of advanced embryo replacement catheters in response to the changing needs of fertility specialists.

The Sure-Pro and Sure-Pro Ultra catheters, which will be used for in-vitro fertilisation procedures, are the result of research by Smiths Medical into the changing needs of its customers.

The new range was showcased in June at National Infertility Day - a patient awareness event in London. Patients said they liked the idea that they could see their embryos being released thanks to the Sure-Pro Ultra catheter, which is visible under ultrasound.

Smiths Medical is the global market leader in embryo transfer products consistently striving to innovate its range and offer advanced fertility solutions to its customers.

ENDS

General media enquiries

Contact our global media and communications team at:

Tom Steiner

Tom Steiner

Head of External Communications

+44 (0) 20 7004 1600

Email Arrow right icon

Please note – the press team can only answer enquiries from accredited members of the press.

Related articles

Roland At MTC Signing

Smiths Group becomes member of the Manufacturing Technology Centre

Read our latest company news as Smiths Group becomes a member of the Manufacturing Technology Centre

Find out more Call to action arrow icon
Blue Box V2

John Crane launches next-generation Coaxial Seal

Find out more Call to action arrow icon
Smiths Group Foundation Logo On Orange Background

Smiths Group Foundation launches second round of charitable donations

Read our latest company news as the Smiths Group Foundation launches a second round of charitable donations

Find out more Call to action arrow icon
Sign up for updates Call to action arrow icon